Deutsche Bank AG Grows Stake in Integer Holdings Co. (NYSE:ITGR)

Deutsche Bank AG grew its holdings in Integer Holdings Co. (NYSE:ITGR - Free Report) by 49.8% in the 4th quarter, according to the company in its most recent filing with the SEC. The firm owned 29,381 shares of the medical equipment provider's stock after buying an additional 9,770 shares during the quarter. Deutsche Bank AG owned approximately 0.09% of Integer worth $3,894,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also bought and sold shares of the business. KBC Group NV lifted its stake in shares of Integer by 83.3% in the 4th quarter. KBC Group NV now owns 1,598 shares of the medical equipment provider's stock valued at $212,000 after purchasing an additional 726 shares during the period. Tributary Capital Management LLC lifted its stake in shares of Integer by 0.8% in the 4th quarter. Tributary Capital Management LLC now owns 287,525 shares of the medical equipment provider's stock valued at $38,103,000 after purchasing an additional 2,289 shares during the period. Principal Financial Group Inc. lifted its stake in shares of Integer by 3.9% in the 4th quarter. Principal Financial Group Inc. now owns 182,267 shares of the medical equipment provider's stock valued at $24,154,000 after purchasing an additional 6,905 shares during the period. Laurus Investment Counsel Inc. purchased a new position in shares of Integer in the 4th quarter valued at approximately $5,422,000. Finally, Congress Asset Management Co. lifted its stake in shares of Integer by 2.0% in the 4th quarter. Congress Asset Management Co. now owns 498,350 shares of the medical equipment provider's stock valued at $66,041,000 after purchasing an additional 9,565 shares during the period. Hedge funds and other institutional investors own 99.29% of the company's stock.

Integer Stock Up 0.3%

Integer stock opened at $121.40 on Tuesday. The firm has a market cap of $4.24 billion, a price-to-earnings ratio of 36.13, a PEG ratio of 1.72 and a beta of 1.03. The stock has a fifty day simple moving average of $118.35 and a two-hundred day simple moving average of $129.47. Integer Holdings Co. has a 12 month low of $104.93 and a 12 month high of $146.36. The company has a current ratio of 2.95, a quick ratio of 2.09 and a debt-to-equity ratio of 0.62.

Integer (NYSE:ITGR - Get Free Report) last posted its earnings results on Thursday, April 24th. The medical equipment provider reported $1.31 EPS for the quarter, topping analysts' consensus estimates of $1.27 by $0.04. The business had revenue of $437.39 million during the quarter, compared to analyst estimates of $428.51 million. Integer had a return on equity of 11.65% and a net margin of 6.92%. The company's quarterly revenue was up 7.3% compared to the same quarter last year. During the same quarter last year, the company earned $1.14 EPS. Equities analysts predict that Integer Holdings Co. will post 6.01 EPS for the current fiscal year.

Insiders Place Their Bets

In related news, CEO Joseph W. Dziedzic sold 338,975 shares of Integer stock in a transaction on Thursday, May 1st. The stock was sold at an average price of $123.17, for a total value of $41,751,550.75. Following the completion of the sale, the chief executive officer now owns 47,000 shares of the company's stock, valued at $5,788,990. The trade was a 87.82% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. Corporate insiders own 2.16% of the company's stock.

Analyst Ratings Changes

A number of research firms have recently commented on ITGR. Oppenheimer cut Integer from an "outperform" rating to a "market perform" rating in a research note on Friday, February 21st. Raymond James raised their target price on Integer from $145.00 to $150.00 and gave the company an "outperform" rating in a research note on Friday, April 25th. StockNews.com upgraded Integer from a "sell" rating to a "hold" rating in a research note on Monday. Benchmark lowered their price objective on Integer from $150.00 to $140.00 and set a "buy" rating for the company in a research note on Friday, April 25th. Finally, Truist Financial set a $150.00 price objective on Integer and gave the company a "buy" rating in a research note on Friday, April 25th. Three analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. According to MarketBeat.com, the company has an average rating of "Moderate Buy" and an average price target of $145.56.

About Integer

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.

Want to see what other hedge funds are holding ITGR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Integer Holdings Co. (NYSE:ITGR - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.